Clinical Trial Update: Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating withdrawal of disease-modifying antirheumatic drugs in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Diakonhjemmet Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED